Annual Drug Patent Expirations for QINLOCK
Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. It is available from one supplier. There are twenty-two patents protecting this drug.
This drug has seventy-four patent family members in eighteen countries.
The generic ingredient in QINLOCK is ripretinib. One supplier is listed for this compound. Additional details are available on the ripretinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
